Biocon

In News

Roche sues Biocon over proposed breast-cancer drug copy - Reuters

Reuters - Jul 30, 2026

Biocon And Sandoz Broaden Japanese Biosimilars Alliance With Pegfilgrastim Nod - insights.citeline.com

insights.citeline.com - Aug 26, 2026

Biocon (NSEI:BIOCON) Stock Gets Fair Value Bump On Margin Focus And Peer Valuation Cues - Yahoo Finance

Yahoo Finance - Aug 09, 2026

Biocon Launches Aflibercept Biosimilar in the United States - JD Supra

JD Supra - Aug 21, 2026

Biocon bags marketing approval for Pegfilgrastim biosimilar in Japan - pharma.economictimes.indiatimes.com

pharma.economictimes.indiatimes.com - Aug 26, 2026

Mutual funds bet across market caps in July 2026: Torrent Pharma, Biocon and Diamond Power among top stock buys - TradingView

TradingView - Aug 23, 2026

Biocon Q1FY27 Total Income at Rs 4,391 Cr, Up 9%; EBITDA at Rs 902 Cr; Net Profit at Rs 141 Cr; Biopharma Revenue Up 17% - Biocon

Biocon - Aug 05, 2026

FDA Approves Biocon’s Biosimilar Ustekinumab Autoinjector - Pearce IP

Pearce IP - Aug 18, 2026

Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg - Business Wire

Business Wire - Aug 03, 2026

Biocon Biologics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 28, 2026

Biocon's Pegfilgrastim Biosimilar Gets Japan MHLW Nod, Sandoz to Exclusively Market Product - Medical Dialogues

Medical Dialogues - Aug 25, 2026

Biocon announces commercial launch of Yesafili in USA - The Pharma Letter

The Pharma Letter - Aug 07, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment